Linked Life Data

191626

Source:http://linkedlifedata.com/resource/pubmed/id/191626

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:191626rdf:typepubmed:Citationlld:pubmed
pubmed-article:191626lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0007289lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0884118lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:191626lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:191626pubmed:issue4lld:pubmed
pubmed-article:191626pubmed:dateCreated1977-5-20lld:pubmed
pubmed-article:191626pubmed:abstractTextCarrageenan, a sulfated polygalactose with known macrophage-toxic properties, was used to ascertain the role of macrophages in resistance to adenovirus type 12 transplantable tumors. A single ip injection of 5 or 10 mg carrageenan led to increased incidence and more rapid growth of tumors in C3H mice. Carrageenan was most effective if given 1 day before tumor inoculation; the effectiveness decreased with increasing intervals before or after tumor cell injection. The macrophage stabilizer poly-2-vinylpyridine N-oxide injected sc (150 mg/kg) 1 day before carrageenan was given reduced the incidence of tumors. These data lend further support to the importance of macrophages in tumor immunity.lld:pubmed
pubmed-article:191626pubmed:languageenglld:pubmed
pubmed-article:191626pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:191626pubmed:citationSubsetIMlld:pubmed
pubmed-article:191626pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:191626pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:191626pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:191626pubmed:statusMEDLINElld:pubmed
pubmed-article:191626pubmed:monthAprlld:pubmed
pubmed-article:191626pubmed:issn0027-8874lld:pubmed
pubmed-article:191626pubmed:authorpubmed-author:RichieE RERlld:pubmed
pubmed-article:191626pubmed:authorpubmed-author:LotzováEElld:pubmed
pubmed-article:191626pubmed:issnTypePrintlld:pubmed
pubmed-article:191626pubmed:volume58lld:pubmed
pubmed-article:191626pubmed:ownerNLMlld:pubmed
pubmed-article:191626pubmed:authorsCompleteYlld:pubmed
pubmed-article:191626pubmed:pagination1171-2lld:pubmed
pubmed-article:191626pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-A...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-M...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-S...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-F...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-N...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-M...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-A...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-C...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-M...lld:pubmed
pubmed-article:191626pubmed:meshHeadingpubmed-meshheading:191626-P...lld:pubmed
pubmed-article:191626pubmed:year1977lld:pubmed
pubmed-article:191626pubmed:articleTitlePromotion of incidence of adenovirus type 12 transplantable tumors by carrageenan, a specific antimacrophage agent.lld:pubmed
pubmed-article:191626pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:191626pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:191626lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:191626lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:191626lld:pubmed